The Rhode Island Neuroscience Symposium gathered 300 researchers, clinicians, industry leaders and entrepreneurs yesterday to ...

This groundbreaking development may enable treatments for inflammatory diseases such as Crohn's and colitis.Researchers at ...

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

Even though people may be getting better at fighting the illness, COVID-19 is still dangerous to vulnerable groups. And so ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of ...

Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause certain types of vaccines that were used for some of ...

I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the ...

IPF affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition develops when lung tissue becomes ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

Recent history makes clear that microbiological disasters can strike anytime. But a longer history should remind us of the ...